CHENE, PATRICK,GARCIA-ECHEVERRIA, CARLOS,JENSEN, MICHAEL RUGAARD,QUADT, CORNELIA,RADIMERSKI, THOMAS,SCHOEPFER, JOSEPH
申请号：
CA2700795
公开号：
CA2700795C
申请日:
2008.10.10
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The use of 5-(2,4-Dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)- isoxazole-3-carboxylic acidethylamide or a tautomer thereof or a pharmaceutically acceptable salt or ahydrate or a solvate for the treatment of cancer of thebladder, the colon, the liver, the lung, the breast, the vagina, the ovaries,the pancreas, the kidney, the stomach, the gastrointestinaltract, the prostate, the head and neck, the peritoneal cavity, the thyroid,the bone, the brain, the central nervous system and/or theblood and/or for the treatment of myelodyspiastic syndrome, systemicmastocytosis, von Hippel-Lindau syndrome, multicentricCastleman disease and/or psioriasis.
